A Syringe and vial are seen in front of a Pfizer logo in this illustration photo. June 24, 2021. Picture: REUTERS/DADO RUVIC
The vaccine, developed with BioNTech, provided 88% protection against hospitalisation and 91.4% against severe illness for an unspecified number of people studied between June 20 and July 17, according to a report Thursday from the health ministry. These results contrast with an earlier study in the New England Journal of Medicine which found that two doses of the Pfizer-BioNTech vaccine offer 88% protection against symptomatic disease caused by the Delta variant, compared to 94% against the Alpha variant that was first discovered in Britain. Public Health England also previously found that the Pfizer and BioNTech shot was 96% effective against hospitalisation.
The Delta variant first emerged in India and is spreading around the globe as governments race to inoculate people, sometimes infecting those already fully vaccinated against Covid-19. The mutation has forced some countries to delay or rethink plans to loosen curbs on businesses, activity and travel.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Two doses of Pfizer, AstraZeneca shots effective against Delta variant, study findsTwo doses of Pfizer or AstraZeneca's Covid-19 vaccine are nearly as effective against the highly transmissible Delta coronavirus variant as they are against the previously dominant Alpha variant, a study published on Wednesday showed.
Source: SowetanLIVE - 🏆 13. / 63 Read more »
Two doses of Pfizer, AstraZeneca shots effective against Delta variant, study findsOfficials say vaccines are highly effective against the Delta variant, now the dominant variant worldwide, though the study reiterated that one shot of the vaccines is not enough for high protection.
Source: TimesLIVE - 🏆 28. / 59 Read more »
Biovac-Pfizer partnership is a breakthrough for Africa: RamaphosaPresident Cyril Ramaphosa has welcomed an announcement of a collaboration between SA's Biovac Institute and global pharmaceutical producer Pfizer. Having to watch my kids cry themselves to sleep because they are hungry breaks my heart😭. I'm unemployed and my family is suffering because of that💔. I'm asking for any tinned food or food nearing the expiry date🙏. I can go days without eating, my kids can't 😭 Great news!! Let the COVID IP protection be waived and allow other countries to produce vaccines to increase global capacity. Also lift sanctions on Cuba so that it can produce its vaccine for poor developing countries Will be packaged* Don't lie.
Source: SowetanLIVE - 🏆 13. / 63 Read more »
Sahpra investigating 1,490 'adverse effects' from J&J and Pfizer jabsThe South African Health Products Regulatory Authority (Sahpra) on Wednesday said it was investigating adverse findings reported from administering the Johnson & Johnson and Pfizer vaccines in SA. I'm happy to join those who are sharing the good news about lisa . I'm not persuading anyone to trade with her but i advise every investor to make the right choice with LISAMARKDONALDT i got my withdrawal safely without any interruption. Just for clarity, by ‘adverse findings’ you mean deaths after taking the vaccine?
Source: TimesLIVE - 🏆 28. / 59 Read more »
Biovac-Pfizer partnership is a breakthrough for Africa: RamaphosaPresident Cyril Ramaphosa has welcomed an announcement of a collaboration between SA's Biovac Institute and global pharmaceutical producer Pfizer. I don't want to argue with anyone. Ramaphosa has failed black south africans dismally
Source: TimesLIVE - 🏆 28. / 59 Read more »
Sahpra investigating 1,490 'adverse effects' from J&J and Pfizer jabsBriefing parliament's portfolio committee on health, Semete-Makokotlela said a report would be released on Friday detailing the analysis being conducted on the adverse findings reported on the two vaccines now being administered in SA.
Source: SowetanLIVE - 🏆 13. / 63 Read more »